Business Context and Reporting Period
Company: Landmark Bancorp, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 22, 2002
Subject: Declaration of a dividend of preferred share purchase rights (a "Rights Plan" or "Poison Pill") to deter hostile takeovers.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a corporate governance mechanism.
Material Changes and Transaction Details
- Dividend Declaration: On September 27, 2001, the Board declared a dividend of one Right for each outstanding share of Common Stock.
- Record Date: February 1, 2002.
- Payment Date: February 13, 2002.
- Underlying Security: Each Right entitles the holder to purchase 1/1,000th of a share of Series A Junior Participating Preferred Stock.
- Purchase Price: $60.00 per 1/1,000th share (subject to adjustment).
- Trigger Threshold: Rights become exercisable if an "Acquiring Person" acquires 15% or more of the Common Stock or announces a tender offer resulting in 15% ownership.
- Expiration: October 3, 2011, unless redeemed or exchanged earlier.
Guidance, Outlook, and Management Commentary
Management Commentary: The filing details the mechanics of the Rights Agreement dated October 3, 2001, between the Company and Landmark National Bank (Rights Agent). The plan is designed to protect shareholders from coercive takeover tactics.
Key Provisions:
- Flip-In: If an Acquiring Person crosses the 15% threshold, non-acquiring Right holders may purchase Common Stock with a market value of two times the exercise price.
- Flip-Over: If the Company is acquired after an Acquiring Person emerges, Right holders may purchase stock of the acquiring entity at a 2x value discount.
- Redemption: The Board may redeem the Rights at $0.01 per Right at any time prior to an Acquiring Person emerging.
- Preferred Stock Rights: The underlying Preferred Stock carries significant voting, dividend, and liquidation preferences designed to dilute the acquirer's interest.
Investor Verification Checklist
- Verify the exact number of outstanding Common Stock shares as of the Record Date (February 1, 2002) to determine the total number of Rights issued.
- Review the full Rights Agreement (Exhibit 99.1) for specific exceptions to the 15% trigger threshold.
- Confirm the current market price of the Common Stock to assess the economic impact of the $60.00 exercise price relative to the 2x flip-in/flip-over provisions.
- Monitor future Board actions regarding the potential redemption of the Rights at the $0.01 price.